Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.
Press releases published on March 26, 2025
Cornish Metals Closes Final Tranche of Fundraising and Appoints Mr. James Whiteside to the Board of Directors
GlobeNewswire
·
March 26, 2025
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, SINGAPORE, CANADA, JAPAN, …
GameStop Announces Proposed Private Offering of $1.3 Billion of Convertible Senior Notes
GlobeNewswire
·
March 26, 2025
GRAPEVINE, Texas, March 26, 2025 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) (“GameStop”) today announced that it intends to offer, subject to market conditions and other factors, $1.3 billion aggregate principal amount of 0.00% Convertible Senior Notes …
Capital Clean Energy Carriers Corp. Joins MIT Maritime Consortium as Founding Member to Advance Research and Development of Groundbreaking Technologies
GlobeNewswire
·
March 26, 2025
ATHENS, Greece, March 26, 2025 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (NASDAQ: CCEC), an international owner of ocean-going vessels, today announced its participation as a Founding Member of the newly established MIT Maritime Consortium, …
Steelcase Reports Fourth Quarter and Fiscal 2025 Results
GlobeNewswire
·
March 26, 2025
Fourth quarter results compared to prior year: Orders grew 9%, driven by 12% broad-based growth in the Americas Gross margin improved 70 basis points Fiscal 2025 results: Orders grew 4%, driven by 6% growth in the Americas compared to prior year Gross …
Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates
GlobeNewswire
·
March 26, 2025
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC) Topline data from registration-intent DENALI Part 2 anticipated by year end 2026 Strengthened management team …
Dyadic Reports 2024 Year-End Financial Results and Business Updates
GlobeNewswire
·
March 26, 2025
Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024 Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to accelerate the C1 platform development timeline to manufacture …
Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc.; Mountain Crest Acquisition…
GlobeNewswire
·
March 26, 2025
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition Corp. Patria Latin American Opportunity Acquisition …
Usio Announces Improved Profitability; Fourth Quarter GAAP Earnings of $0.02 per share and Full Year GAAP Earnings of $0.12 per share
GlobeNewswire
·
March 26, 2025
Full Year Revenues up in each of ACH & Complementary Services, Card and Output Solutions Business Units Record Full Year 2024 Dollar Processing Volume of $7.1 Billion, a 33% Increase Compared to Fiscal 2023; Transactions Processed also up a Strong 26% Year …
Usio Increases and Extends Share Repurchase Program
GlobeNewswire
·
March 26, 2025
SAN ANTONIO, March 26, 2025 (GLOBE NEWSWIRE) -- Usio, Inc: (Nasdaq: USIO), a leading FinTech company that operates a full stack of integrated, cloud-based electronic payment and embedded financial solutions, today announced that its Board of Directors has …
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
GlobeNewswire
·
March 26, 2025
Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and neurological diseases Initial data for NKX019 in multiple autoimmune indications expected in second half of 2025 …
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
March 26, 2025
FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended December 31, 2024 were $56.1 million Met All Financial …
Snail, Inc. Reports Fourth Quarter & Full Year 2024 Financial Results
GlobeNewswire
·
March 26, 2025
CULVER CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (NASDAQ: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, today announced financial results for its fourth …
Oxbridge Re Holdings Limited Reports Fiscal 2024 Results
GlobeNewswire
·
March 26, 2025
GRAND CAYMAN, Cayman Islands, March 26, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (“Oxbridge Re” or the “Company”), which together with its subsidiaries, is engaged in the business of tokenized Real-World Assets (“RWAs”), …
Inventiva reports its 2024 full year results and provides a business update
GlobeNewswire
·
March 26, 2025
Revenues of €9.2 million for the full year of 2024 Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 million Structured Financing closed with aggregate gross proceeds of €116 million Last patient screened in the …
Inventiva publie ses résultats financiers annuels 2024 et fait le point sur son activité
GlobeNewswire
·
March 26, 2025
Chiffre d'affaires de 9,2 millions d'euros pour l’année 2024 Trésorerie et équivalents de trésorerie à 96,6 millions d’euros au 31 décembre 2024 Levée d’un produit brut de 116 millions d’euros dans le cadre de la première tranche du Financement Structuré …
Oxford Lane Capital Corp. Announces Declaration of Distributions on Common Stock for the Months Ending July 31, August 31, and September 30, 2025
GlobeNewswire
·
March 26, 2025
GREENWICH, Conn., March 26, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (the “Company”) today announced …
Lee Enterprises Extends Limited-Duration Shareholder Rights Plan in Light of Hoffmann Letter
GlobeNewswire
·
March 26, 2025
DAVENPORT, Iowa, March 26, 2025 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ: LEE) (“Lee” or the “Company”) today announced that its Board of Directors (the “Board”) has unanimously approved an amendment to the Company’s existing shareholder …
Heartflow Closes $98 Million Convertible Notes Financing
GlobeNewswire
·
March 26, 2025
MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced additional investments in the company of approximately $98 million through the sale and issuance of …
MRF 2025 Resource Limited Partnership Final Closing April 29, 2025
GlobeNewswire
·
March 26, 2025
TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Middlefield, on behalf of MRF 2025 Resource Limited Partnership (“MRF 2025” or the “Partnership”), is pleased to announce that it has completed the second closing of the initial public offering of MRF 2025 Class …
[Latest] Global Fabry Disease Treatment Market Size/Share Worth USD 7.02 Billion by 2034 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
GlobeNewswire
·
March 26, 2025
Austin, TX, USA, March 27, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Fabry Disease Treatment Market Size, Trends and Insights By Treatment (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate …